We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Crossject franchit une nouvelle étape clé dans la fabrication de ZEPIZURE® Fabrication réussie d’un autre Lot Règlementaire de ZEPIZURE® sur le nouveau site de fabricationUne étape importante qui...
Crossject achieves key ZEPIZURE® manufacturing milestone Successful completion of an additional Registration Batch of ZEPIZURE® at new manufacturing siteMilestone complements the satisfying...
Successful completion of an additional Registration Batch of ZEPIZURE® at new manufacturing siteMilestone complements the satisfying results from previous batches under stability studies, and is...
Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright Dijon, France, 15 juillet 2024, 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), société...
Dijon, France, July 15th 2024, 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company in advanced phases of development and registration for ZEPIZURE®, its...
Crossject to attend H.C. Wainwright 26th Annual Global Investment Conference Dijon, France, July 15th 2024, 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company...
Crossject obtient 6,9 millions d'euros de financement public dans le cadre du plan France 2030, pour accélérer le développement de ZENEO® Adrénaline Contribution clé à l'accélération du...
Crossject is awarded a 6.9 million euros financing from the French Government, as part of the France 2030 innovation plan, to accelerate the development of ZENEO® Epinephrine Key contribution to...
Key contribution to the acceleration of the development of ZENEO® EpinephrineFinancial support includes mainly grants, as well as subsidized loansFrance 2030 Plan dedicated to supporting French...
Crossject : Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 5 juillet 2024 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), «...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.315 | -54.7826086957 | 0.575 | 0.575 | 0.225 | 46683820 | 0.26839157 | DE |
4 | -0.39 | -60 | 0.65 | 0.8 | 0.225 | 15333670 | 0.36693095 | DE |
12 | -0.415 | -61.4814814815 | 0.675 | 0.9 | 0.225 | 8568601 | 0.52248339 | DE |
26 | -0.865 | -76.8888888889 | 1.125 | 1.125 | 0.225 | 8110663 | 0.62392606 | DE |
52 | -2.24 | -89.6 | 2.5 | 2.75 | 0.225 | 8051346 | 0.94788665 | DE |
156 | -128.24 | -99.7976653696 | 128.5 | 153 | 0.225 | 3396014 | 1.08587922 | DE |
260 | -128.24 | -99.7976653696 | 128.5 | 153 | 0.225 | 3396014 | 1.08587922 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions